Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV–III randomized open-label comparative study of Kaletra-based therapy in HIV infection
2008-003748-12Phase 3Active
- Sponsor
- Fundación SEIMC-GeSIDA
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Fundación SEIMC-GeSIDA. Started Aug 2008; status: active.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-003748-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003748-12.